Strategic Fit: Simbec-Orion Strategic Combination

The strategic combination of Caidya and Simbec-Orion brings together complementary geographic reach, clinical capabilities, therapeutic expertise, and a shared commitment to client and patient needs. In this discussion, leaders from Caidya and Simbec-Orion explain how Simbec-Orion’s strong European presence and early-phase capabilities complement Caidya’s established strength in the United States and APAC. The conversation also highlights expanded support from healthy-volunteer and early-phase studies through Phase II, Phase III, and registrational trials, along with laboratory and investigational drug manufacturing capabilities. Together, Caidya and Simbec-Orion aim to offer sponsors broader global coverage, deeper expertise, and continuity across the clinical development lifecycle.